Monrovia, California News Releases
25 News Releases · Displaying 1 - 25
VP's at GSK and AstraZeneca preent at Cancer Drugs R&D conferenceRobert Copeland, VP of Biology, Oncology Center of Excellence in Drug Discovery at GlaxoSmithKline to give keynote presentation at 5th Cancer Drugs R&D conference on February 21-22, 2008 in Phoenix. - December 28, 2007 Big Pharma to Present at GTCbio’s 3rd Imaging in Drug Development Conference in March 2008
Presenters from GSK, Pfizer, Abbott, Schering-Plough, Bristol-Myers Squibb, GE, Siemens, NIH and more to speak at GTCbio’s 3rd Imaging in Drug Development conference on March 17-18, 2008 in San Diego. - December 28, 2007 Joost J. Oppenheim, Chief of the Laboratory of Molecular Immunoregulation at NCI, NIH to present on Regulation of T Regulatory Cells, January 28, 2008
Joost J. Oppenheim, Chief of the Laboratory of Molecular Immunoregulation at NCI, NIH, will be the honored keynote speaker at the 6th Cytokines and Inflammation conference to be held January 28-29, 2008 in Orlando, FL. - December 24, 2007 Thomas Waldmann, Chief, NCI to give keynote talk at Immunodiagnostics & Immunomonitoring conference
Thomas Waldmann, Chief of Metabolism & Head of Cytokine Immunology/ Immunotherapy at NCI to give keynote presentaion at 2nd Immunodiagnostics & Immunomonitoring conference December 6-7, 2007 - November 22, 2007 Kenna Anderes of Pfizer, Michael Shi of Novartis and Joseph Paul Eder of AstraZeneca to give featured presentations at Oncology Biomarkers: From Discovery to Validation conference January 2008
Kenna Anderes of Pfizer Global R&D, Michael Shi of Novartis and Joseph Paul Eder of AstraZeneca to give featured presentations at Oncology Biomarkers: From Discovery to Validation conference on January 14-15, 2008. - November 11, 2007 Robert Copeland, VP, Oncology Drug Discovery, GSK to give keynote talk at Cancer Drugs conference
Robert Copeland, VP of Biology, Oncology Center of Excellence in Drug Discovery at GlaxoSmithKline to give keynote presentation at 5th Cancer Drugs R&D conference on February 21-22, 2008 in Phoenix. - November 11, 2007 Gary Peltz, Head of Genetics and Genomics at Roche Palo Alto to give keynote presentation on Computational Genetics at PK/PD track of 3rd Modern Drug Discovery & Development Summit
Gary Peltz, Head of Genetic/Genomics at Roche to keynote presentation at PK/PD track at 3rd Modern Drug Discovery & Development Summit on November 28-30, 2007 in San Francisco. - October 25, 2007 Dr. Stephen K. Burley, CSO and SVP of Research at SGX Pharmaceuticals will give the Keynote presentation at 3rd Modern Drug Discovery & Development Summit
Dr. Stephen K. Burley, CSO and SVP of Research at SGX Pharmaceuticals will give the Keynote presentation at GTCbio’s Drug Design & Lead Discovery conference – one of six tracks at the 3rd Modern Drug Discovery & Development Summit on November 28-30, 2007 in San Francisco. - October 19, 2007 Dr. David Kaslow, Vice President of Infectious Diseases and Vaccines at Merck to give Keynote presentation at 3rd Modern Drug Discovery & Development Summit
Dr. David Kaslow, VP of Infectious Diseases and Vaccines at Merck will give the Keynote presentation at GTCbio’s Biological Therapeutics conference – one of six tracks at the 3rd Modern Drug Discovery & Development Summit on November 28-30, 2007 at the Hyatt Regency San Francisco Airport. - October 19, 2007 GTCbio’s 5th International Conference on Vaccines: All Things Considered
GTCbio announces it’s the 5th anniversary of its vaccine conference held annually in Washington D.C. - October 15, 2007 Neil Bodick, COO of Chorus – Eli Lilly & Co. to Give Plenary Keynote Address at 3rd Modern Drug Discovery & Development Summit
COO of Chorus, Eli Lilly & Co. announced as Plenary Keynote Speaker for the 3rd Modern Drug Discovery & Development Summit (M3D). - October 13, 2007 GTCbio’s 3rd Modern Drug Discovery and Development Summit
GTCbio announces its flagship event – the 3rd Modern Drug Discovery and Development Summit (M3D) on Nov. 28-30, 2007 in San Francisco – featuring four plenary keynote speeches from top level execs at Pfizer, Eli Lilly, Wyeth as well as Nobel Laureate Ferid Murad at UT Houston. - October 11, 2007 SVP and Site Head of Pfizer La Jolla to Give Plenary Keynote Address at 3rd Modern Drug Discovery & Development Summit
SVP and Site Head of Pfizer La Jolla announced as Plenary Keynote Speaker for the 3rd Modern Drug Discovery & Development Summit (M3D). - October 10, 2007 Nobel Laureate Ferid Murad to Give Plenary Keynote Address at 3rd Modern Drug Discovery & Development Summit
Ferid Murad who received a Nobel Prize in Physiology and Medicine will be among the plenary keynote presenters at GTCbio’s 3rd Modern Drug Discovery and Development Summit on November 28-30 in San Francisco, CA. - July 28, 2007 TakeMyPayments.com Announces Record Automotive Lease Transfer Rates
The Number of Lease Transfers Hit Record Levels at TakeMyPayments; More Autmotive Leases Posted on TakeMyPayments.com Result in an Initiated Transfers. - June 28, 2007 Pfizer to Present on Safety Biomarkers, Regulatory Strategies, & Risk Management in Oncology IND at GTCbio’s Rediscovering Biomarkers Conference-July 23-24, 2007, San Diego, CA
Dr. Howard Fingert, Senior Director, Signal Transduction Development Program at Pfizer Oncology will present on Safety Biomarkers, Regulatory Strategies, and Risk Management in Oncology IND Programs at GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference taking place on July 23-24, 2007 at the San Diego Marriott La Jolla in La Jolla, CA. - June 23, 2007 Caprional Pharma to Present on Secreted Proteins as Biomarkers at GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference (July 23-24, 2007, San Diego, CA)
Dr. Daniel Chelsky, Chief Scientific Officer at Caprion Pharmaceuticals will present on Secreted Proteins as Biomarkers: Catching Them at the Source at GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference taking place on July 23-24, 2007 at the San Diego Marriott La Jolla in La Jolla, CA. - June 23, 2007 LabCorp to Present on Development of Companion Diagnostics at GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference (July 23-24, 2007, San Diego, CA)
Dr. Steven M. Anderson, National Director of Research and Development at Laboratory Corporation of America will present on Development of Companion Diagnostics: Role of Clinical Reference Laboratories at GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference taking place on July 23-24, 2007 at the San Diego Marriott La Jolla in La Jolla, CA. - June 23, 2007 PDD to Present on Pharmacodynamic Biomarkers at GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference (July 23-24, 2007, San Diego, CA)
Dr. Aaron B. Kantor, Executive Director of Cell and Molecular Biology, Biomarker Discovery Sciences at PPD, Inc. will present on Pharmacodynamic Biomarkers Identified with Broad-Based Phenotyping at GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference taking place on July 23-24, 2007 at the San Diego Marriott La Jolla in La Jolla, CA. - June 23, 2007 Boehringer-Ingelheim to Present on Unique Monoclonal Antibodies at GTCbio’s Rediscovering Biomarkers Conference (July 23-24, San Diego, CA)
Biotech/Pharmaceutical conference (GTCbio's Rediscovering Biomarkers: Detection, Development and Validation conference) features Boehringer-Ingelheim at San Diego event. - May 12, 2007 Abbott Laboratories to Present at GTCbio’s 2nd Assay Development & High Throughput Screening Conference (May 31-June 1, Boston, MA)
Dr. Yaya Liu, Research Investigator at Abbott Laboratories in Illinois will give a presentation entitled “Fluorescence Polarization Assay Development for Cyclophilin, a Challenging PPIase Target for Antiviral Drug Discovery” at GTCbio’s 2nd Assay Development & High Throughput Screening Conference on May 31-June 1 in Boston, MA. - May 12, 2007 NIH Chemical Genomics Center to Present at GTCbio’s 2nd Assay Development & High Throughput Screening Conference (May 31-June 1, Boston, MA)
Dr. Ron Johnson, Team Leader at the National Institutes of Health Chemical Genomics Center in Bethesda, Maryland is presenting on “Quantitative High-Throughput Screening of Cell-Based Assays” at GTCbio’s 2nd Assay Development & High Throughput Screening Conference on May 31-June 1 in Boston, MA. - May 12, 2007 Bristol-Myers Squibb to Present on Success of High Throughput Kinetic-Read Assays at GTCbio’s 2nd Assay Development & High Throughput Screening Conference (May 31-June 1, Boston, MA)
Kingsley Appiah, Research Scientist in Lead Discovery at Bristol-Myers Squibb in Wallingford, Connecticut will present on “High Throughput Kinetic-Read Assays: Delivering Significantly Improved Assay Performance” at GTCbio’s 2nd Assay Development & High Throughput Screening Conference on May 31-June 1 in Boston, MA. - May 12, 2007 GTCbio Announces 2007 Fellowship Awards and Charitable Donation
GTCbio announces fellowship winners who receive monetary award to help in the advancement of scientific research. GTCbio also makes a donation to the Doctors around the World Charity. - April 19, 2007 Scientists Look to Treat Tumors with the Help of Man’s Best Friend
The aim of this conference is to provide an in-depth look at various model systems and their potential to accelerate drug discovery and development. Topics to be covered are Model Organisms as Research & Development Tools, Clinical & Preclinical Developments, Transgenic Model Organisms, Target Validation, Toxicology & Efficacy and Therapeutic Strategies for Specific Diseases. - November 05, 2006